Aristotle University Of Thessaloniki (AUTH)
Η επίδραση της ερυθροποιητίνης στην οξεία νεφρική ισχαιμία: πειραματική μελέτη σε επίμυες
Abstract
dc:descriptionThe effect of erythropoietin on acute renal ischemia.Experimental study in rats.Erythropoietin (EPO) exhibits pleiotropic properties. The aim of this study was to investigate the effect of EPO on acute renal ischemia/reperfusion (RI/R). Male Wistar rats randomly divided into two groups: I/R (n=12) and EPO I/R group (500 IU/Kg, i.p, 20 min prior ischemia, n=15), were subjected to bilateral renal ischemia for 45 min. Three subgroups were defined in each group, in which reperfusion occurred in 6, 24 and 48 hours respectively. Rats subjected to identical surgical procedure without occlusion of renal pedicles constituted the control group (n=6). Renal injury was assessed by measurement of serum biochemical markers (urea and creatinine) and histological grading. The expression of Cyt c, nNOS, iNOS, eNOS and COX-2 was studied immunohistochemically, while Fas/FasL, nNOS and Cyt c were evaluated by RT-PCR. I/R caused deterioration of the biochemical markers and installation of histological lesions. EPO pretreatment reduced I/R-induced tubular injury and ameliorated renal function. Fas/FasL and Cyt c mRNA were isolated from normal kidneys. Fas/FasL mRNA expression did not change in both groups. RI/R caused an increase in the gene and protein expression of Cyt c (mostly in 48 and 6hrs respectively). EPO limited gene expression of Cyt c in 48hrs and restricted its protein expression mostly in 6hrs. The expression of nNOS in normal kidneys was decreased in 6hrs of reperfusion, while it tended to be restored later. EPO maintained its expression in the controls’ levels in 6hrs. Limited and faint expression of iNOS was observed in normal kidneys. iNOS immunostaining was gradually increased from 6 to 24hrs of reperfusion in tubules and vessels. EPO restrained the intensity of iNOS expression. The presence of eNOS was evident in normal renal vessels and tubules. An induction of eNOS expression occurred in 6 and 24hrs of reperfusion, while in the EPO group it was noted only in 24hrs and in tissues with severe damage. COX-2 is normally expressed in macula densa and tubules. An increase of COX-2 was noted in 6hrs, which subsided later. EPO restricted the inductive peak of 6hrs. Conclusively, the administration of EPO was renoprotective. RI/R and EPO did not affect the expression of Fas/FasL. The early induction of Cyt c suggests its participation in the subsequent injury installation. The beneficial effect of EPO manifests itself through the intrinsic apoptotic pathway. nNOS participates in normal renal function. Its early, post-ischemic reduction, except of consequence of injury, was possibly directly harmful. The inductive effect of EPO on nNOS correlated with an increased number of viable tubules. iNOS post-ischemic induction correlated with the installation of tubular injury. Its attenuation by EPO is a result of its anti-inflammatory and antioxidant properties. The increase of eNOS subsided after the installation of severe injury. The effect of EPO was not related to eNOS directly. COX-2 participates in renal homeostatic mechanisms. Its induction during reperfusion is interpreted as a further activation of these functions or/and as a trigger for inflammation. The beneficial effect of EPO restricts the mobilisation of homeostatic mechanisms or/and the harmful role of COX-2.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Xanthopoulou, Kyriaki
- Ξανθοπούλου, Κυριακή
Subjects
dc:subject × 26- Ερυθροποιητίνη
- Νεφρός
- Νεφρική ισχαιμία/επαναιμάτωση
- Οξεία νεφρική βλάβη
- Πειραματικό πρότυπο
- Κυτόχρωμα C
- Συνθάσες του μονοξειδίου του αζώτου
- Κυκλοοξυγενάση-2
- Erythropoietin
- Kidney
- Renal ischemia/reperfusion
- Acute kidney injury
- Experimental model
- FAS
- FasL
- Cytochrome C
- Nitric oxide synthases
- nNOS
- iNOS
- eNOS
- Cyclooxygenase-2
- COX-2
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/34572